Sudden collapse during haemodialysis due to immune-mediated heparin-induced thrombocytopaenia

Nephrology Dialysis Transplantation

Volumn 21, Issue 6, 2006, Pages 1721-1724

  Davenport, Andrew ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Cardiac arrest; Haemodialysis complication; Heparin; HIT; Pseudo pulmonary embolus; Thrombocytopaenia

Indexed keywords

CARBON DIOXIDE; ENOXAPARIN; HEPARIN; OXYGEN;

AGED; ARTERIAL CARBON DIOXIDE TENSION; ARTERIAL OXYGEN TENSION; ARTERIAL PRESSURE; ARTICLE; ASYSTOLE; BLOOD FLOWMETRY; CASE REPORT; CAUSE OF DEATH; DEVICE REMOVAL; DIALYSIS CATHETER; DIALYSIS MEMBRANE; ENZYME LINKED IMMUNOSORBENT ASSAY; HEART ARREST; HEART INFARCTION; HEMODIALYSIS; HEPARIN INDUCED THROMBOCYTOPENIA; HUMAN; HYPOXIA; IMMUNOPATHOGENESIS; KIDNEY FAILURE; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRESSURE MEASUREMENT; PRIORITY JOURNAL; RESUSCITATION; THROMBOCYTE COUNT; TREATMENT FAILURE; VENOUS PRESSURE;

AGED; CATHETERIZATION; HEPARIN; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; PURPURA, THROMBOCYTOPENIC, IDIOPATHIC; RENAL DIALYSIS; SHOCK;

EID: 33745982563     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfl124     Document Type: Article

References (17)

1. Yamamoto S, Koide M, Matsuo M et al. Heparin induced thrombocytopenia in haemodialysis patients. Am J Kidney Dis 1996; 28: 82-85
2. Greinacher A, Zinn S, Wizemann, Birk UW. Heparin induced antibodies as a risk factor for thromboembolism and haemorrhage in patients undergoing chronic haemodialysis. Lancet 1996; 348: 764
3. Davenport A. The management of heparin induced thrombocytopenia during renal replacement therapy. Hemodial Int 2001; 5: 81-85
4. Boon DM, van Vliet HH, Zietse R, Kappers-Klunne MC. The presence of antibodies against a PF4-heparin complex in patients on haemodialysis. Thromb Haemostat 1996; 76: 480
5. Reilly RF. The pathophysiology of immune mediated heparin induced thrombocytopenia. Seminars Dialysis 2003; 16: 54-60
6. Sitter T, Spannagl M, Banas B, Schiffl H. Prevalence of heparin-induced antibodies in haemodialysis patients. Nephron 1998; 79: 245-246
7. O'Shea SI, Sands JJ, Nudo SA, Ortel TL. Frequency of antiheparin platelet factor 4 antibodies in haemodialysis patients and correlation with recurrent vascular access thrombosis. Am J Haematol 2002; 69: 72-73
8. Davenport A. Management of heparin-induced thrombocytopenia during continuous renal replacement therapy. Am J Kid Dis 1998; 32: E3
9. Popov D, Zarrabi MH, Foda H, Graber M. Pseudopulmonary embolism: Acute respiratory distress in syndrome of heparin-induced thrombocytopenia. Am J Kidney Dis 1997; 29: 449-452
10. Agharazii M, Plamondon I, Lebel M, Douville P, Desmeules S. Estimation of heparin leak into the systemic circulation after central venous catheter heparin lock. Nephrol Dial Transplant 2005; 20: 1238-1240
11. Warkentin TE, Greinacher A. eds. Heparin induced thrombocytopenia. 3rd edn. Marcel Dekker, New York: 2004
12. Warkentin TE, Heddle NM. Laboratory diagnosis of immune heparin-induced thrombocytopenia. Curr Hematol Rep 2003; 2: 148-157
13. Perkins RM, Lee JD, Rutberg S, McCune DE, Cooper RH. Thrombocytopenia and acute respiratory distress associated with intravenous bolus heparin exposure. Hosp Phys 2003; 39: 59-61
14. Davenport A. Central venous catheters for haemodialysis: How to overcome the problems. Haemodial Int 2000; 4: 78-82
15. Cines DB, Tomaski A, Tannenbaum S. Immune endothelial-cell injury in heparin-associated thrombocytopenia. N Engl J Med 1987; 316: 581-589
16. Blank M, Shoenfeld Y, Tavor S et al. Anti-platelet factor 4/heparin antibodies from patients with heparin induced thrombocytopenia provoke direct activation of microvascular endothelial cells. Int Immunol 2002; 14: 121-129
17. Tejedor Alonso MA, Lopez Revuelta K, Garcia Bueno MJ et al. Thrombocytopenia and anaphylaxis secondary to heparin in a haemodialysis patient. Clin Nephrol 2005; 63: 236-240